Life Science Tools Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 143.72 Billion |
| Market Size (2029) | USD 201.80 Billion |
| CAGR (2024 - 2029) | 7.02 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Life Science Tools Market Analysis
The Life Science Tools Market size is estimated at USD 143.72 billion in 2024, and is expected to reach USD 201.80 billion by 2029, growing at a CAGR of 7.02% during the forecast period (2024-2029).
Globally, the COVID-19 pandemic positively impacted the growth of the life science tools market with the rapid development of diagnostics, fast-tracked regulatory clearances, and increased distribution in various countries to help curb the spread of the virus. Various diagnostic procedures have always been essential in the detection of infectious diseases. Currently, several molecular assays and immunoassays are in place to detect COVID-19. However, in the aftermath of the pandemic, there has been increased research in the life sciences industry to prepare for any unexpected global pandemic burden. For instance, in September 2022, the WHO issued a guidance framework for the responsible use of life science tools. The Framework calls on leaders and other stakeholders to mitigate risks and safely govern dual-use research, which has a clear benefit but can be misused to harm humans, other animals, agriculture, and the environment. Hence, with the increasing focus on life science, the market studied is expected to grow significantly in the coming years.
Genomic technologies are increasingly being used globally to understand and contribute to developing new diagnostic tests or procedures for various diseases, boosting the market's growth. For instance, in September 2022, Becton, Dickinson, and Company (BD) and CerTest Biotec commercially launched their new molecular polymerase chain reaction (PCR) assay for the monkeypox virus for the US and global markets. The company has stated that this PCR assay will only be available for research purposes. With such new launches, the market is expected to witness strong growth over the forecast period.
Furthermore, technological advancements associated with sequencing technologies, chromatography methods, mass spectrometry, and other products led to the increasing adoption of these tools in hospitals, research labs, and diagnostic laboratories. According to the WHO 2021 Factsheet, 680,000 people died from HIV-related causes, and 1.5 million people acquired HIV. Thus, a high patient population will boost the demand for treatment and further increase the use of life sciences tools for identifying, diagnosing, and monitoring the progression of several infectious diseases.
Furthermore, the rising demand for diagnostic tests for a variety of infectious diseases will spur the development of life science tools for diagnosing the target population, propelling overall market growth over the forecast period.
Life Science Tools Market Trends
Life Science Tools in Separation Technologies is Estimated to Witness a Healthy Growth Rate Over the Forecast Period
The major factors driving the separation technologies segment include growing investments in pharmaceutical R&D and the increasing adoption of chromatography technologies by the life sciences industries.
Globally, the COVID-19 pandemic positively impacted the life science instruments market. The outbreak of COVID-19 resulted in an increased number of diseases, which led to a subsequent increase in research and development activities. Increasing investment in drug discovery is expected to fuel the growth of the separation technology segment. For example, in May 2022, Cipla announced the commercialization of its COVID-19 PCR kit in India. The real-time RT-PCR test kit has been validated by an Indian Council of Medical Research (ICMR)-approved center.
Separation technologies include immunoprecipitation, chromatographic techniques, automated purification systems, and others that aid in diagnosing and treating COVID-19. For example, according to the Indian Journal of Medical Research 2021, a study was conducted in a tertiary care teaching hospital in northern India to assess a rapid immunoassay-based chromatographic test in the diagnosis of COVID-19. The results of the study showed that immunoassay-based rapid chromatographic tests can help in the rapid detection, isolation, and treatment of patients with COVID-19.
In addition, this technology is widely adopted by several industries due to several advantages associated with chromatography technology. Benefits such as reducing the need for large columns increase the efficiency and productivity of the production process. Thus, increased adoption of multiple separation technologies across sectors would increase the demand for life science tools and drive segment growth.
The increasing prevalence of infectious diseases worldwide will encourage the adoption of life science tools. For example, according to the WHO 2021 Factsheet, 1.5 million people died of tuberculosis in 2021, and an estimated 10 million people contracted tuberculosis (TB) worldwide. It has been steadily declining in recent years. However, it is still at a much higher level.
Thus, the above-mentioned factors are expected to drive segment growth over the forecast period.
North America is Expected to Hold a Significant Market Share over the Forecast Period
The major factors driving market growth in North America include the rising number of genomic procedures, increasing research and development expenditure, the presence of a large number of major players, growing adoption among biopharmaceutical companies, product launches, and technological advancements.
With the outbreak of COVID-19 in the United States, there has been an increase in the number of diagnostic procedures, leading to market growth. Thus, diagnostic procedures with new technologies have proven beneficial in managing COVID-19 and are driving the growth of the life sciences instruments market.
The biopharmaceutical industry in the United States has expanded significantly to include new product types such as synthetic vaccines, nanoantibodies, rDNA, fusion proteins, immunoconjugates, soluble receptors, and immunotherapeutics. The pharmaceutical and biopharmaceutical industries' increased R&D investment in life science tools, research, and academics is expected to drive the market.
For example, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), the US biopharmaceutical industry is one of the world leaders in new drug development. The entire biopharmaceutical and pharmaceutical industry invested an estimated USD 91.1 billion in research and development (R&D) in 2021, compared to about USD 83 billion invested in research and development (R&D) in the previous year.
Furthermore, the increasing adoption of novel drug delivery systems and the rising prevalence of infectious disease cases are expected to fuel the life science tools market in the region over the forecast period.
Life Science Tools Industry Overview
The life science tools market is moderately competitive. The market players adopted strategies such as product approval and launches, acquisitions, partnerships, and agreements. Some of the market players include Becton, Dickinson and Company, Agilent Technologies, Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, GE Healthcare, and Bruker QIAGEN.
Life Science Tools Market Leaders
-
Becton, Dickinson and Company
-
Agilent Technologies
-
Illumina, Inc
-
Thermo Fisher Scientific Inc.
-
F. Hoffmann-La Roche Ltd.
*Disclaimer: Major Players sorted in no particular order
Life Science Tools Market News
- April 2022: Sysmex Europe launched its Flow Cytometer XF-1600, which has received CE marking, indicating its compliance with the European IVD Regulation and IVD use.
- March 2022: Beckman Coulter Life Sciences launched a solution to manual sample preparation and data management bottlenecks in clinical flow cytometry: the CellMek SPS. This fully automated sample preparation system (SPS) offers on-demand processing for a multitude of sample types to help laboratories expand their capabilities.
Life Science Tools Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Demand for Biopharmaceuticals and Increasing Funding for Life Science Research
4.2.2 Rising Incidence of Target Infectious Diseases and Genetic Disorders
4.3 Market Restraints
4.3.1 High Cost of Instruments
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Type
5.1.1 Instruments
5.1.2 Consumables
5.1.3 Services
5.2 By Technology
5.2.1 PCR and qPCR
5.2.2 Sanger Sequencing
5.2.3 Separation Technologies
5.2.4 Flow Cytometry
5.2.5 Nucleic Acid Microarray
5.2.6 Mass Spectrometry
5.2.7 Other Technologies
5.3 By Application
5.3.1 Proteomics Technology
5.3.2 Genomic Technology
5.3.3 Cell Biology Technology
5.3.4 Other Applications
5.4 By End User
5.4.1 Research Laboratories
5.4.2 Diagnostic Laboratories
5.4.3 Other End Users
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Agilent Technologies Inc.
6.1.3 Illumina Inc.
6.1.4 Thermo Fisher Scientific Inc.
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Bio-Rad Laboratories Inc.
6.1.7 Merck KGaA
6.1.8 GE Healthcare
6.1.9 Bruker Corporation
6.1.10 Qiagen NV
6.1.11 Danaher Corporation
6.1.12 Abbott Laboratories Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Life Science Tools Industry Segmentation
As per the scope, life science tools comprise consumables, instruments, reagents, and other services that are used to study the various areas of biotechnology, genetics, molecular biology, and cell biology. The Life Science Tools Market is Segmented by Product (Instruments, Consumables, and Services), by Technology (PCR & qPCR, Sanger Sequencing, Separation Technologies, Flow Cytometry, Nucleic Acid Microarray, Mass Spectrometry, and Other Technologies), by Application (Proteomics Technology, Genomic Technology, Cell Biology Technology, and Other Applications), by End User (Research Laboratories, Diagnostic Laboratories, and Other End Users), and by Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above-mentioned segments.
| By Type | |
| Instruments | |
| Consumables | |
| Services |
| By Technology | |
| PCR and qPCR | |
| Sanger Sequencing | |
| Separation Technologies | |
| Flow Cytometry | |
| Nucleic Acid Microarray | |
| Mass Spectrometry | |
| Other Technologies |
| By Application | |
| Proteomics Technology | |
| Genomic Technology | |
| Cell Biology Technology | |
| Other Applications |
| By End User | |
| Research Laboratories | |
| Diagnostic Laboratories | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Life Science Tools Market Research FAQs
How big is the Life Science Tools Market?
The Life Science Tools Market size is expected to reach USD 143.72 billion in 2024 and grow at a CAGR of 7.02% to reach USD 201.80 billion by 2029.
What is the current Life Science Tools Market size?
In 2024, the Life Science Tools Market size is expected to reach USD 143.72 billion.
Who are the key players in Life Science Tools Market?
Becton, Dickinson and Company, Agilent Technologies, Illumina, Inc, Thermo Fisher Scientific Inc. and F. Hoffmann-La Roche Ltd. are the major companies operating in the Life Science Tools Market.
Which is the fastest growing region in Life Science Tools Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Life Science Tools Market?
In 2024, the North America accounts for the largest market share in Life Science Tools Market.
What years does this Life Science Tools Market cover, and what was the market size in 2023?
In 2023, the Life Science Tools Market size was estimated at USD 133.63 billion. The report covers the Life Science Tools Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Life Science Tools Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
What are the key challenges in the Life Science Tools Market?
The key challenges in the Life Science Tools Market are a) Budgetary limitations faced by research funding agencies and academic institutions can restrict their purchasing power b) Competition from emerging markets offering lower-cost alternatives can put pressure on pricing and profitability
What are the key challenges in the Life Science Tools Market?
The key challenges in the Life Science Tools Market are a) Budgetary limitations faced by research funding agencies and academic institutions can restrict their purchasing power b) Competition from emerging markets offering lower-cost alternatives can put pressure on pricing and profitability
Life Science Tools Industry Report
The global life science tools market is witnessing rapid growth, driven by technological advancements in sequencing, chromatography, and mass spectrometry, alongside an uptick in R&D investments. A surge in diseases like cancer and diabetes fuels a persistent demand for innovative treatments, propelling the development of gene and cell therapies. Key innovations in cell biology and genomics are revolutionizing drug discovery and biologics manufacturing, aiming to enhance treatment efficacy and cost-efficiency.
The healthcare and biopharmaceutical sectors are increasingly depending on these tools for cutting-edge genomic and proteomic research. North America leads the charge, benefiting from a robust research ecosystem and a stronghold of market leaders, while the Asia Pacific region is rapidly catching up, due to strategic investments and expansion efforts. Strategic collaborations and product innovations by market players are pivotal, keeping the life science market size on an upward trajectory and firmly at the forefront of healthcare and therapeutic innovation.
Market size, market analysis, market report, market research, market share, and market trends are critical components driving the industry forward. The industry report offers an in-depth industry analysis and market forecast, providing valuable industry information and market outlook. The report example, available as a report PDF, highlights the market segmentation and industry statistics, ensuring a comprehensive market review.
The growth rate of the market is supported by industry research and industry sales, with market data indicating significant market growth. The market leaders are setting trends and making market predictions that shape the industry outlook. The industry size and market value are continually increasing, reflecting the dynamic nature of the life science tools market.
